A roundup of recent health news includes delayed medical results, Pope Francis's health update, oncology initiatives, food safety concerns, a rare surgery, and threats against a doctor. Read more...

Cantor Fitzgerald has issued "strong-buy" ratings for multiple stocks, including Immunovant, Ardelyx, Kura Oncology, and Mesoblast. Meanwhile, Bank of America adjusts price targets for Gilead Sciences and Immunovant. Read more...

A roundup of recent health news, including a warning about parasite weight loss schemes, a foundation for cancer patients, mental health in schools, oncology training, and an update on Pope Francis's health. Read more...